Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M, Smith WP, Chien J, Herschkowitz JI, Troester MA, Beck M, Inciardi M, Gatewood J, May L, Cusick T, McGinness M, Ricci L, Fan F, Tawfik O, Marks JR, Knapp JR, Yeh HW, Thomas P, Carrasco DR, Fields TA, Godwin AK, Behbod F. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Breast Cancer Res. 2015 Sep 17; 17:128.
-
Animals
-
beta Catenin
-
Biomarkers, Tumor
-
Breast Neoplasms
-
Carcinoma, Ductal, Breast
-
Carcinoma, Intraductal, Noninfiltrating
-
Disease Progression
-
Epithelial-Mesenchymal Transition
-
Female
-
Humans
-
Mice
-
Mice, Inbred NOD
-
Mice, SCID
-
Neoplasm Proteins
-
Neoplasm Recurrence, Local
-
Receptor, ErbB-2
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Transcription Factors
-
Transcription, Genetic
-
Transcriptome
-
Up-Regulation
-
Wnt Proteins